SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102